How And When To Administer COVID Antibody Cocktail Drug Jun 01, 2021, 15:19 IST
An 84-year-old man from Haryana became the first person in India to be administered the Covid drug cocktail over a 30 minute intravenous supply and has now been successfully used in various parts of the country. This treatment first came into the limelight after it was administered to former US President Donald Trump when he tested positive for Covid last year.
The cocktail drug is a combination of two fast-acting antibodies - Casirivimab and Imdevimab - is seen as a cutting-edge treatment that provides protection to Covid-19 patients with mild and moderate symptoms.
While advocating rational use of the Covid-19 monoclonal antibody cocktail, former ICMR scientist Dr Raman Gangakhedkar said the treatment is unlikely to result in further mutations of the virus.